awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50530986-E85C727D-C6E5-4A8E-8CC5-DCA10D5B401F
Q50530986-E85C727D-C6E5-4A8E-8CC5-DCA10D5B401F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50530986-E85C727D-C6E5-4A8E-8CC5-DCA10D5B401F
Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads.
P2860
Q50530986-E85C727D-C6E5-4A8E-8CC5-DCA10D5B401F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50530986-E85C727D-C6E5-4A8E-8CC5-DCA10D5B401F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2511db1507d63c3277259c1293b0de9d783424b2
P2860
Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled t